Report
EUR 13.82 For Business Accounts Only

Despite a double improvement and a slightly more favourable rating at Slightly Negative, EQM MDSTM.PTNS.LP remains unattractive

EQM MDSTM.PTNS.LP (US), a company active in the Pipelines industry, has received a double requalification by the independent financial analyst theScreener. Its fundamental valuation now shows 1 out of 4 stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) and an improvement in the market risk perception allow raising the general evaluation to Slightly Negative. As of the analysis date April 3, 2020, the closing price was USD 13.43 and its target price was estimated at USD 11.66.
Underlying
EQM Midstream Partners LP

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch